Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
- 28 October 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 325 (2) , 445-452
- https://doi.org/10.1016/j.bbrc.2004.10.052
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in miceInternational Immunology, 2004
- Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoVPhysiological Genomics, 2004
- Identification of an Antigenic Determinant on the S2 Domain of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Capable of Inducing Neutralizing AntibodiesJournal of Virology, 2004
- Inactivated SARS-CoV Vaccine Prepared from Whole Virus Induces a High Level of Neutralizing Antibodies in BALB/c MiceDNA and Cell Biology, 2004
- One Year After Outbreak, SARS Virus Yields Some SecretsScience, 2004
- Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with ReceptorJournal of Virology, 2004
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2Journal of Biological Chemistry, 2004
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003